Publications in collaboration with researchers from University of Nebraska Medical Center (13)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes

    Nature Genetics, Vol. 56, Núm. 9, pp. 1878-1889

  3. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2021

  1. A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

    Blood Cancer Journal

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

    Leukemia, Vol. 35, Núm. 1, pp. 18-30

  4. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

    The Lancet Oncology, Vol. 22, Núm. 3, pp. e105-e118

2017

  1. Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice

    Blood, Vol. 129, Núm. 19, pp. 2645-2656

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508

  2. Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma

    Nature Communications, Vol. 5

2007

  1. A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma

    Leukemia and Lymphoma, Vol. 48, Núm. 1, pp. 39-45

2003

  1. Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: Evidence for failure of regulatory mechanisms suppressing autoimmunity

    Transplantation, Vol. 75, Núm. 11, pp. 1832-1840

1990

  1. Molecular structure of the rearranged t-cell gamma chain gene in a human leukemia which expresses its product

    Leukemia and Lymphoma, Vol. 3, Núm. 2, pp. 145-150